Low dose ASA

DRUG3 trials

Sponsors

University of Pennsylvania, Boehringer Ingelheim, Penn State University

Conditions

Acute Coronary SyndromeAgingCoronary Artery DiseaseMigraine DisordersStable Angina

Early Phase 1

Identification of Critical Thermal Environments for Aged Adults

RecruitingNCT04284397

Penn State UniversityAging

Start: 2020-12-30End: 2027-02-27Target: 190Updated: 2026-01-27

Phase 3

Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

CompletedNCT02183688

Boehringer IngelheimMigraine Disorders

Start: 1998-09-30Updated: 2014-07-08

Unknown Phase

PGD2 Formation in Vascular Injury

TerminatedNCT01001260

University of PennsylvaniaAcute Coronary Syndrome, Coronary Artery Disease, Stable Angina

Start: 2007-08-31End: 2012-01-31Updated: 2019-06-11